维普期刊资源整合服务平台（V6.5）

139篇 您的检索式：作者名="KUTI JL"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Use of Monte Carlo simulation to design an optimized pharmacodynamic dosing strategy for meropenem显示文摘	Kuti JL Dandekar PK Nightingale CH	2003	J Clin Pharmacol2003，43，10：	1
2	Population pharmacokinetics and pharmacodynamics of piperacillin/tazobaetam in patients with complicat- ed intra-abdominal infection显示文摘	Li C Kuti JL Nightingale CH	2005	J Antimicrob Chemother2005，56，2：	1
3	Optimizing dosing strategies of antibacterials utilizing pharmacodynamic principles: impact on the development of resistance 显示文摘	DeRuke CA Lee SY Kuti JL	2006	Drugs2006，66，：	1
4	Comparison of phanmrodynamic target attainment between healthy subjects and patients for ceftazidime and meropenem 显示文摘	Kuti JL Horowita S Nightingatle CH et ol	2005	Pharmacotherapy2005，25，7：	1
5	Comparative phannacodynamics for intravenous antibiotics against gram - negative bacteria in Europe between 2002 and 2006 : a report from the OPTAMA program显示文摘	Koomanachai P Crandon JL Kuti JL	2009	Int J Antimicrob Agents2009，33，：	1
6	Pharmacodynamic target at-tainment of oral beta-lactams for the empiric treatment of acute otitis media in children显示文摘	Fallon RM Kuti JL Doern GV	2008	Paediatr Drugs2008，10，：	1
7	Pharmacodynamic pro- filing of continuously infused piperacillin/tazobactam against Pseu- domonas aeruginosa using Monte Carlo analysis显示文摘	Kuti JL Nightingale CH Quintilianid R	2002	Diagn Microbiol In- fecti Dis2002，44，1：	1
8	Probability of achieving requisite pharmacodynamic exposure for oral beta-lactam regimens against Haemophilus in uenzae in children显示文摘	Pichichero ME Doern GV Kuti JL	2008	Paediatr Drugs2008，10，：	1
9	Optimizing antimicrobial pharmacodynamics , dosage strategies for meropenem 显示文摘	Mattoes HM Kuti JL Drusano GL	2004	Clin Ther2004，26，8：	1
10	Use of Monte Carlo simulation to design an optimized phannacodynamic dosing strategy for meropenem显示文摘	Kuti JL Dandekar PK Nightingale CH	2003	J Clin Phannacol2003，43，10：	1
11	Population pharmacokinetic analysis and dosing regimen optimization of meropenem in adult patients显示文摘	Li C Kuti JL Nightingale CH		0，，10：	1
12	Optimal dosing of piperacillin-tazobactam for the treatment of Pseudomonas aeruginosa infections: prolonged or continuous infusion? 显示文摘	Kim A Sutherland CA Kuti JL	2007	Pharmacotherapy2007，27，11：	1
13	Optimising antibiotic dosing regimens based on pharmacodynamic target attainment against Pseudomonas aeruginosa collected in Hungarian hospitals 显示文摘	Ludwig E Konkoly-Thege M Kuti JL	2007	Int J Antimicrob Agents2007，30，5：	1
14	Cost-effective approaches to the treatment of community-acquired pneumonia in the era of resistance显示文摘	Kuti JL Capitano B Nicolau DP	2002	Phermocoeconomics2002，20，8：	1
15	Acute physiology and chronic health evaluation II score is a better predictor of mortality than IBMP-10 in patients with ventilator-associated pneumonia 显示文摘	Wiskirchen DE Kuti JL Nieolaa DP	2011	Surg Infect (Larehmt)2011，12，5：	1
16	Population pharmacokinetics and pharmacodynamics of meropenem in pediatric patients显示文摘	Du X Li C Kuti JL		0，，01：	1
17	Pharmacodynamic modeling of intravenous antibiotics against gram negative bac teria collected in the United States显示文摘	Koomanachai P Bulik CC Kuti JL		0，，04：	1
18	Probability of a- chieving requisite pharmacodynamic exposure for oral be- ta lactam regimens against Haemophilus influenzae in children显示文摘	Pichichero ME Doern GV Kuti JL	2008	Paediatr Drugs2008，10，6：	1
19	Pharmacodynamic compari- son of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase - negative staphylococci col- lected from hospitals in Brazil 显示文摘	Kuti JL Kiffer CR Mendes CM	2008	Clin Microbiol Infect2008，14，：	1
20	Use of Monte Carlo Simulation to design an optimized phannacodynamic dosing strategy for meropenem显示文摘	Kuti JL Pharm D Dandekar PK	2003	J Clin Pharmacol2003，43，：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示